Portland, OR, Sept. 27, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Neurological Biomarkers Market size was estimated at $5.4 billion in 2021 and is expected to hit $18.9 billion by 2031, registering a CAGR of 13.6% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Download Free Sample Report (141 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/3555
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Market Size in 2031 | $18.9 Billion |
| CAGR | 13.6% |
| Segments Covered | Type, Application, and Region. |
| Drivers | Rise in the prevalence of neurological diseases such as Huntington’s disease, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and others |
| Opportunities | High-end technological advancements and launch of various products |
| Restraints | Threat of cyber security and data breach |
Covid-19 scenario-
- There was a steep increase in demand for neurological biomarkers due to rise in neurological diseases such as Parkinson’s and Alzheimer’s disease.
- At the same time, recent FDA approvals of varied neurological biomarkers supplemented the market growth even more.
The global neurological biomarkers market is analyzed across type, application, and region. The report takes in an exhaustive analysis of the segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/3555
Based on type, the proteomic segment held more than one-fourth of the total market revenue in 2021, and is expected to dominate by 2031. The same segment would also manifest the fastest CAGR of 14.1% throughout the forecast period.
Based on application, the Alzheimer’s disease segment garnered more than half of the total market revenue in 2021, and is expected to dominate by 2031. The same segment would also project the fastest CAGR of 13.8% throughout the forecast period.
Based on region, the global neurological biomarkers market across North America generated more than half of the total market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, on the other hand, would also showcase the fastest CAGR of 8.7% during the forecast period. The other provinces analyzed through the report include Europe and LAMEA.
The key market players analyzed in the global neurological biomarkers market report include Bio-Rad Laboratories, Inc., Biomérieux, F. Hoffmann-La Roche Ltd., Myriad Genetics, Inc., Perkinelmer Inc., Quanterix, Shimadzu Corporation, Neurobio, Merck KGAA, and Thermo Fisher Scientific, Inc. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Over The Counter (OTC) Test Market By Product Type (Glucose Monitoring Test, Pregnancy & Fertility test, Coagulation Monitoring Test, Urinalysis Test, Cholesterol Test, and Other Test), Technology (Lateral Flow Assays, Immunoassays, and Dipsticks), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021--2030
Women Health and Beauty Supplements Market By Ingredient (Vitamins & Minerals, Botanical, Proteins & Amino Acids and Others), Consumer Group (Pre & postnatal, Premenstrual syndrome, menopause, Others), Application (Beauty and Women Health), Distribution Channel (Hypermarkets/Supermarkets, Health & Beauty Retail Stores, Drug Stores, and Online Pharmacies & E-Commerce Sites): Global Opportunity Analysis and Industry Forecast, 2021-2030
Body Fat Measurement Market by Product (Calipers, Body scales, Others), by Technique (Bio Impedance Analysis, Air Displacement Plethysmography, Dual Emission Xray Absorptiometry, Hydrostatic Weighing, Others), by End User (Hospitals and Clinics, Fitness Clubs and Wellness Centers, Home Users): Global Opportunity Analysis and Industry Forecast, 2021-2031
Body Fat Reduction Market by Procedure Type (Surgical and Non-Surgical), Gender (Male and Female), and End User (Hospitals & Clinics, Medical Spas, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
Healthcare CRM Market by Component (Software and Services), Application (Customer Service & Support, Marketing, CRM Analytics, and Others), Deployment Model (On-Premise, Cloud, and Hybrid), and End User (Healthcare Providers and Healthcare Payers): Opportunity Analysis and Industry Forecast, 2021-2030
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Follow Us on Blog: https://www.globalhealthcareindustry.com/
